Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkers. This evidence concerns the gene PIK3CA and pancreatic neuroendocrine tumor.